Devintec Sagl
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Performance and Safety of Afluxin® in Patients With Gastroesophageal Reflux Disease (NCT06984484) | Devintec Sagl | 2025-07-02 |
| Gelsectan® in the Treatment of Patients With Diarrhoea-predominant Irritable Bowel Syndrome (NCT06681012) | Devintec Sagl | 2024-10-22 |
| Devintec OR-AT0222 Oral Gel for the Treatment of Canker Sores: A Double Blind, Randomized, Placebo Controlled Clinical Investigation (NCT05959824) | Devintec Sagl | 2023-05-08 |
| Efficacy and Safety, Tolerability of GA-AT0119 in IBS-C (NCT05240521) | Devintec Sagl | 2021-11-01 |
Track Devintec Sagl automatically
Every clearance here is in the API, with alerts when new ones post.